key: cord-310740-7dong29x
authors: Alkeridy, Walid A.; Almaghlouth, Ibrahim
title: Reply to: Neurological, Cognitive and Behavioral Disorders During COVID‐19: The Nitric Oxide Track
date: 2020-06-24
journal: J Am Geriatr Soc
DOI: 10.1111/jgs.16670
sha: 
doc_id: 310740
cord_uid: 7dong29x

This letter comments on the letter by Cedric Annweiler

To the Editor: We read with great interest the letter of Annweiler et al. 1 They propose an intriguing mechanism for cognitive impairment related to coronavirus disease 2019 . We would like to clarify a couple of points related to our case. First, although we wanted to exclude COVID-19 encephalitis as a possibility, this was not possible without cerebrospinal fluid analysis and magnetic resonance imaging, which was refused by our patient. Our patient fulfilled the Confusion Assessment Method criteria for delirium on admission, which was our working diagnosis. 2 In fact, the rapid improvement in his cognitive function might argue against COVID-19 encephalitis. Second, our patientʼs usual medication included lisinopril, an angiotensin-converting enzyme 2 inhibitor, for treatment of hypertension in the context of diabetes mellitus, type II. Possibly, the mechanism proposed by Annweiler et al 1 pertaining to the nitric oxide track could explain the rapid improvement in our patient's cognition following just a brief period of supportive management.

It is important to emphasize that delirium is a heterogeneous entity caused by multiple causative factors and complex underlying pathogenesis. [3] [4] [5] In fact, nitric oxide has long been implicated in the pathogenesis of delirium and cognitive impairment. 6, 7 Whether the nitric oxide track will prove to have a central role in the acute manifestations of COVID-19related cognitive impairment remains to be seen. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection could activate multiple downstream molecular pathways affecting each individual distinctly. 7 We propose that the underlying mechanism of COVID-19 central nervous system manifestation or delirium depends on the interaction between SARS-CoV-2 activated molecular pathways and the individual related factors, including age, COVID-19 severity, individualʼs underlying genetic susceptibility, vascular risk factors, premorbid cognitive function, use of certain medication, and comorbidities.

Several other mechanisms have been linked to COVID-19 neurological and cognitive manifestations. 8, 9 However, the retrospective design of the study by Mao et al limits our ability to infer the causal mechanism of cognitive decline in COVID-19 patients. 8 We propose possible mechanisms of COVID-19related cognitive dysfunction (Table 1) , which could help researchers in studying the specific pathways associated with each possible mechanism. Finally, the core message of our study is for clinicians to proactively screen for delirium in hospitalized older adults. 10 Once delirium is identified, a comprehensive individualized assessment should be pursued, including COVID-19 testing during this pandemic. 10 Table 1 Possible mechanisms of COVID-19-related cognitive dysfunction Indirect CNS involvement through inflammatory or immune response Viral encephalitis due to direct CNS invasion COVID-19-related organ failure (lung, heart, kidney, or vasculature) and metabolic dysfunction COVID-19 ICU-related delirium Large-vessel stroke or lacunar stroke syndrome Exacerbation or unmasking of underlying cognitive impairment or neurodegenerative process Medication-related adverse reaction Other unknown mechanism

cognitive and behavioral disorders during COVID-19: the nitric oxide track

Clarifying confusion: the confusion assessment method: a new method for detection of delirium

Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study

Delirium in elderly people

Delirium in elderly adults: diagnosis, prevention and treatment

Delirium: Acute Brain Dysfunction in the Critically Ill

Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2

Neurologic manifestations of hospitalized patients with coronavirus disease

The spectrum of neurologic disease in the severe acute respiratory syndrome coronavirus 2 pandemic infection: neurologists move to the frontlines

A unique presentation of delirium in a patient with otherwise asymptomatic COVID-19